% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • culleyjc52 culleyjc52 Jan 3, 2012 7:25 PM Flag

    TEVA's new CEO announcement

    Liked the first paragraph after the announcement:

    Teva Pharmaceuticals (TEVA) is up 6.7% today after the company announced that it will replace CEO Shlomo Yanai with Jeremy Levin, a former Bristol-Myers Squibb (BMY) executive.

    Yanai helped the company grow its revenue from about $8 billion to an estimated $22 billion in 2012, but the stock had suffered in the past year, in part on concerns about its top-selling MS drug Copaxone.

    Teva, the world’s largest generic drug maker, has lots of opportunities to grow as big drugs go off patent in the next couple of years. But Copaxone is facing all sorts of challenges.

17.97+0.19(+1.07%)Nov 25 4:00 PMEST